A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...

Solid Biosciences' DMD gene therapy shows promise with SGT-003 and strong cash backing through 2027. Click here to read an ...

We came across a bullish thesis on Sarepta Therapeutics, Inc. on Stock Region Research’s Substack by Stock Region. In this ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding ...

In its complete response letter, the FDA cited insufficient evidence establish deramiocel's effectiveness for cardiomyopathy ...

Teijin Automotive Technologies North America has rebranded as CSP following its acquisition by Aurelius Private Equity. The ...

About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance ...

Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed in the U.S. District Court for ...

As part of its transition to a standalone, privately held business, Teijin Automotive Technologies North America has changed ...

The law firm of Kessler Topaz Meltzer & Check, LLP ( informs investors that a securities class action lawsuit has been filed against Sarepta Therapeutics, Inc. ("Sarepta") ( NASDAQ: SRPT) on behalf ...

Mr. Mahatme brings decades of experience in strategic finance, capital formation, and operational leadership to support ...

ICER’s upcoming report could shed light on how the launch price of newly approved drugs affects overall cost and access from ...